Table 2 Clinical characteristics of patients with MSO confined to the ovary
From: Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary
Patients’ characteristics | N | % | Recurrence | N = 124 |
|---|---|---|---|---|
Age (y) | 125 | Â | Yes | 27 (21.8%) |
Mean 46.3 ± 14.2 |  |  | Mean/Median time (y) | 5.6/3.0 |
Median 46.0 (Range 11–80) |  |  | NA | 1 |
Elevated CA 125 | N = 33 |  | Sites of Recurrence | N = 27 |
Yes | 12 | 36.4% | Peritoneum | 12 |
Time of follow-up (y) | N = 125 |  | Liver | 8 |
Mean 5.12 | Â | Â | Lung | 7 |
Median 2.75 (Range 0.08–41) |  |  | Bone | 5 |
Pathology | N = 125 |  | Lymph nodes | 4 |
PTC | 56 | 44.8% | Diaphragm | 4 |
FVPTC | 39 | 31.2% | Bowel | 4 |
FTC | 23 | 18.4% | Omentum | 2 |
Mixed FTC + PTC | 3 | 2.4% | Fallopian tube | 2 |
poorly differentiated TC | 4 | 3.2% | Contralateral ovary | 2 |
Synchronous primary thyroid carcinoma | N = 125 |  | Bladder | 1 |
Yes | 9 | 7.2% | Mediastinum | 1 |
Lymph nodes examination | N = 19 |  | Uterus | 1 |
Positive | 0 | Â | Spleen | 1 |
Mass size (cm) 7.7 ± 3.6 (0.5–18.0) | N = 73 |  | Adrenal | 1 |